Compare HERE & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HERE | MIST |
|---|---|---|
| Founded | 2019 | 2003 |
| Country | China | Canada |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.6M | 95.3M |
| IPO Year | 2022 | 2019 |
| Metric | HERE | MIST |
|---|---|---|
| Price | $1.53 | $0.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $4.60 | ★ $5.86 |
| AVG Volume (30 Days) | 14.3K | ★ 1.1M |
| Earning Date | 12-01-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $147.62 |
| Revenue Next Year | $182.30 | $476.43 |
| P/E Ratio | $2.83 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $0.70 |
| 52 Week High | $5.80 | $3.06 |
| Indicator | HERE | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 28.74 | 34.67 |
| Support Level | $1.50 | N/A |
| Resistance Level | $1.94 | $1.42 |
| Average True Range (ATR) | 0.05 | 0.06 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 20.45 | 8.54 |
Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.